Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Moodys
Colorcon
Dow
McKesson

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

FOUGERA PHARMS Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for FOUGERA PHARMS, and what generic alternatives to FOUGERA PHARMS drugs are available?

FOUGERA PHARMS has one hundred and fourteen approved drugs.

There are five US patents protecting FOUGERA PHARMS drugs.

There are fifty-nine patent family members on FOUGERA PHARMS drugs in twenty-seven countries and forty-four supplementary protection certificates in fifteen countries.

Summary for FOUGERA PHARMS
International Patents:59
US Patents:5
Tradenames:54
Ingredients:46
NDAs:114

Drugs and US Patents for FOUGERA PHARMS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms PANDEL hydrocortisone probutate CREAM;TOPICAL 020453-001 Feb 28, 1997 RX Yes Yes   Start Trial   Start Trial
Fougera Pharms BETAMETHASONE DIPROPIONATE betamethasone dipropionate GEL, AUGMENTED;TOPICAL 075276-001 May 13, 2003 AB RX No Yes   Start Trial   Start Trial
Fougera Pharms ALCLOMETASONE DIPROPIONATE alclometasone dipropionate OINTMENT;TOPICAL 076884-001 Jul 18, 2005 AB RX No Yes   Start Trial   Start Trial
Fougera Pharms BETAMETHASONE DIPROPIONATE betamethasone dipropionate CREAM;TOPICAL 019137-001 Jun 26, 1984 AB RX Yes Yes   Start Trial   Start Trial
Fougera Pharms CALCIPOTRIENE calcipotriene SOLUTION;TOPICAL 078305-001 May 6, 2008 AT RX No No   Start Trial   Start Trial
Fougera Pharms TEMOVATE clobetasol propionate SOLUTION;TOPICAL 019966-001 Feb 22, 1990 DISCN Yes No   Start Trial   Start Trial
Fougera Pharms Inc BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT;TOPICAL 019141-001 Sep 4, 1984 AB RX Yes Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for FOUGERA PHARMS

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fougera Pharms CUTIVATE fluticasone propionate LOTION;TOPICAL 021152-001 Mar 31, 2005 7,300,669   Start Trial
Fougera Pharms TEMOVATE clobetasol propionate SOLUTION;TOPICAL 019966-001 Feb 22, 1990 3,721,687   Start Trial
Fougera Pharms ACLOVATE alclometasone dipropionate CREAM;TOPICAL 018707-001 Dec 14, 1982 4,124,707   Start Trial
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,639,738   Start Trial
Fougera Pharms SOLARAZE diclofenac sodium GEL;TOPICAL 021005-001 Oct 16, 2000 5,985,850   Start Trial
Fougera Pharms Inc VEREGEN sinecatechins OINTMENT;TOPICAL 021902-001 Oct 31, 2006 5,968,973   Start Trial
Fougera Pharms CUTIVATE fluticasone propionate OINTMENT;TOPICAL 019957-001 Dec 14, 1990 4,335,121*PED   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for FOUGERA PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Gel 3% ➤ Subscribe 2009-12-16
➤ Subscribe Lotion 0.05% ➤ Subscribe 2008-07-28

Supplementary Protection Certificates for FOUGERA PHARMS Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1304992 2013/044 Ireland   Start Trial PRODUCT NAME: CLINDAMYCIN AND TRETINOIN; REGISTRATION NO/DATE: PA1332/043/001 20130322
0548114 SPC/GB97/064 United Kingdom   Start Trial PRODUCT NAME: MOMETASONE FUROATE MONOHYDRATE; REGISTERED: FR AMM 343012.6 19970219; UK 00201/0216 19970410
0284288 12/1998 Austria   Start Trial PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: 1-22102, 1-22103 19970918; FIRST REGISTRATION: DE 37393.00.00, 37393.01.00 19961203
1448186 488 Finland   Start Trial
0031058 98C0008 Belgium   Start Trial PRODUCT NAME: TAZAROTENE; NAT. REGISTRATION NO/DATE: NL22604 19970922; FIRST REGISTRATION: DE - 37393.00.00 19961203
1458369 08C0024 France   Start Trial PRODUCT NAME: ADAPALENE - PEROXYDE DE BENZOLE; REGISTRATION NO/DATE IN FRANCE: NL 33724 DU 20080123; REGISTRATION NO/DATE AT EEC: 40440 DU 20071218
0112669 96C0002 Belgium   Start Trial PRODUCT NAME: MOMETASONE FUROATE; NAT. REGISTRATION NO/DATE: NL 19601 19950919; FIRST REGISTRATION: GR - 10681/89 19900622
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Boehringer Ingelheim
AstraZeneca
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.